Metropolis Healthcare 

₹2,135.1
15
-₹9.8-0.46% Friday 09:59

統計

當日最高
2,189.55
當日最低
2,130
52週最高
2,189.55
52週最低
1,360.05
成交量
159,682
平均成交量
159,664
市值
111.18B
市盈率
81.78
股息收益率
0.19%
股息
4

即將到來

股息

0.19%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
-20.63%
1年增長率
-66.67%

收益

14Nov預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
5.28
6.56
7.83
9.1
預期每股收益
9.10039878475
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 METROPOLIS.NSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
Show more...
首席執行官
Ms. Ameera Sushil Shah
員工
4313
國家
IN
ISIN
INE112L01020

上市公司